Ayahuasca dimethyltryptamine, and psychosis: a systematic review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 23 February 2017

Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine

Dakic, V., Nascimento, J. M., Sartore, R. C., de Moraes Maciel, R., de Araujo, D. B., Ribeiro, S., ... & Rehen, S. K. | bioRxiv | 13 February 2017

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016

Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm

Hendricks, P. S., & Grob, C. S. | Rational Suicide in the Elderly | 29 October 2016

Psychedelic Psychotherapy Insights From 25 Years of Research

Richards, W. A. | Journal of Humanistic Psychology | 29 September 2016

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

Szabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. | Frontiers in Neuroscience | 14 September 2016

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Gallimore, A. R. and Strassman, R. | Frontiers in Pharmacology | 30 June 2016

Neuropharmacology of N,N-Dimethyltryptamine

Carbonaro, T. M., & Gatch, M. B. | Brain Research Bulletin | 25 April 2016

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Szabo, A., & Frecska, E. | Neural Regeneration Research | 1 April 2016

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class

Dinger, J., Woods, C., Brandt, S. D., Meyer, M. R., & Maurer, H. H. | Toxicology Letters | 17 November 2015

Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents

Carlini, E. A., & Maia, L. O. | 9 November 2015

Acute Biphasic Effects of Ayahuasca

Schenberg E.E., Alexandre J.F.M., Filev R., Cravo A.M., Sato J.R., Muthukumaraswamy S.D., et al. | PLoS ONE | 30 September 2015

Psychedelic medicine: a re-emerging therapeutic paradigm

Yensen, R., & Johnson, M. W. | Canadian Medical Association Journal | 08 Sep 2015

Psychedelic medicine: A re-emerging therapeutic paradigm

Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. | CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne | 08 September 2015

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Szabo, A. | Frontiers in Immunology | 14 July 2015

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.

Pic-Taylor, A., da Motta, L. G., de Morais, J. A., Junior, W. M., Santos, A. D. F. A., Campos, L. A., ... & Caldas, E. D. | Behavioural processes | 3 June 2015

A Note on the Docking of some Hallucinogens to the 5-HT2A Receptor

Gómez-Jeria, J. S., & Robles-Navarro, A. | Journal of Computational Methods in Molecular Design | April 2015

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F., de Lourdes Bastos, M., de Pinho, P. G., & Carvalho, M. | Archives of toxicology | 16 April 2015

Concise synthesis of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine starting with bufotenine from Brazilian Anadenanthera ssp..

Moreira, L. A., Murta, M. M., Gatto, C. C., Fagg, C. W., & dos Santos, M. L. | Natural product communications | 10 April 2015

Serotonergic psychedelics temporarily modify information transfer in humans

Alonso, J. F., Romero, S., Mañanas, M. À., & Riba, J. | International Journal of Neuropsychopharmacology | 28 March 2015

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 14 March 2015

What Can Neuroscience Tell Us About the Potential of Psychedelics in Healthcare?

Mackenzie, R. | Current Drug Abuse Reviews | 23 February 2015

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., & Riba, J. | Current Topics in Behavioral Neuroscience | 6 February 2015

Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’)

Kortekaas, R., & Breeksema, J. J. | Current Drug Abuse Reviews | 28 January 2015

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. | Journal of Psychopharmacology | 13 January 2015